- The global poultry diagnostics market is forecast to reach $250 million by 2031, growing at a 7.1% CAGR from 2026.
- Rising commercial poultry production and increasing pressure to detect infectious diseases early are fueling market growth.
- PCR-based diagnostics are expected to be the fastest-growing testing segment due to their speed and sensitivity.
- Swab samples continue to dominate diagnostic testing because of their compatibility with molecular and immunoassay-based tests.
- The Asia-Pacific region is projected to experience the fastest growth as poultry production, disease surveillance, and veterinary infrastructure continue to expand.
The global poultry diagnostics market is expected to see steady growth through 2031 as producers, veterinary laboratories, and animal health organizations invest in technologies that improve disease detection and flock health management.
According to a new market report from ResearchAndMarkets.com, the market is projected to grow from USD 0.18 billion in 2026 to USD 0.25 billion by 2031.
Growing commercial poultry production, heightened biosecurity measures, and continued concerns over economically significant diseases—including avian influenza, Newcastle disease, and infectious bronchitis—are driving demand for faster and more accurate diagnostic testing.
Molecular diagnostics continue to gain ground
PCR-based diagnostics are expected to record the strongest growth during the forecast period. The technology enables highly sensitive detection of pathogens before clinical signs appear, allowing producers to respond more quickly to emerging disease threats.
The report also notes continued advances in automated PCR systems, robotic ELISA platforms, and portable diagnostic devices that improve testing efficiency while supporting large-scale surveillance programs.
Swabs remain the preferred sample type
Swab samples—including oropharyngeal and cloacal swabs—continue to represent the largest sample segment because they are easy to collect, minimally invasive, and well suited for both PCR and ELISA testing.
Asia-Pacific expected to lead market growth
The Asia-Pacific region is forecast to register the highest growth rate during the forecast period, supported by expanding poultry production, increasing consumer demand for poultry products, and continued investment in disease surveillance programs.
Government initiatives, improvements in veterinary infrastructure, and heightened awareness of disease prevention are also expected to accelerate adoption of advanced diagnostic technologies throughout the region.
Competitive landscape
The report identifies a broad range of companies participating in the poultry diagnostics market, including IDEXX Laboratories, Thermo Fisher Scientific, Zoetis, BioChek, Bio-Rad Laboratories, INDICAL Bioscience, BioNote, Gold Standard Diagnostics, and several other manufacturers focused on veterinary diagnostic technologies.
Information sourced from the company’s press release.
